Hypromellose: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 46: Line 46:
* changes in vision
* changes in vision
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|useInPregnancyAUS=There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInPregnancyAUS=There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
Line 63: Line 61:
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.


Line 91: Line 87:


<!--How Supplied-->
<!--How Supplied-->
|howSupplied=*
|storage=* Store at room temperature 15°-30°C (59°-86°F).
* Do not freeze.
* Keep box for complete information.
|packLabel=<!--Patient Counseling Information-->
|packLabel=<!--Patient Counseling Information-->
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.

Revision as of 21:42, 12 January 2015

Hypromellose
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Hypromellose is a ophthalmic solution that is FDA approved for the treatment of dryness of the eye and prevent further irritation.. Common adverse reactions include eye pain, changes in vision..

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

  • Relieves dryness of the eye.
  • Temporarily relieves discomfort due to minor irritations of the eye or from exposure to wind and sun.
  • As a protectant against further irritation.

Dosage

  • Put 1 or 2 drops in the affected eye(s) as needed.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Hypromellose in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Hypromellose in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Hypromellose in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Hypromellose in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Hypromellose in pediatric patients.

Contraindications

There is limited information regarding Hypromellose Contraindications in the drug label.

Warnings

  • For external use only.
  • Do not use if sealed bottle tip is broken or punctured.
  • If solution changes color or becomes cloudy, do not use.

When using this product

  • To avoid contamination, do not touch tip of container to any surface.
  • Replace cap after using.

Stop use and ask a physician

  • If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a doctor.

Precautions

  • Description

Adverse Reactions

Clinical Trials Experience

  • eye pain
  • changes in vision

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Hypromellose in the drug label.

Drug Interactions

There is limited information regarding Hypromellose Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Hypromellose in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Hypromellose in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Hypromellose during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Hypromellose with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Hypromellose with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Hypromellose with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Hypromellose with respect to specific gender populations.

Race

There is no FDA guidance on the use of Hypromellose with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Hypromellose in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Hypromellose in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Hypromellose in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Hypromellose in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Hypromellose Administration in the drug label.

Monitoring

There is limited information regarding Monitoring of Hypromellose in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Hypromellose in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Hypromellose in the drug label.

Pharmacology

There is limited information regarding Hypromellose Pharmacology in the drug label.

Mechanism of Action

Structure

File:Hypromellose01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Hypromellose in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Hypromellose in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Hypromellose in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Hypromellose in the drug label.

How Supplied

There is limited information regarding Hypromellose How Supplied in the drug label.

Storage

  • Store at room temperature 15°-30°C (59°-86°F).
  • Do not freeze.
  • Keep box for complete information.

Images

Drug Images

{{#ask: Page Name::Hypromellose |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Hypromellose |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Hypromellose in the drug label.

Precautions with Alcohol

  • Alcohol-Hypromellose interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ Empty citation (help)
  2. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Page Name=Hypromellose
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Hypromellose
 |Label Name=Hypromellose11.png

}}

{{#subobject: 

 |Label Page=Hypromellose
 |Label Name=Hypromellose11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Hypromellose&oldid=1054068"